دورية أكاديمية
A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12 weeks
| العنوان: | A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12 weeks |
|---|---|
| المؤلفون: | O’Brien, M.E.R., Myerson, J.S., Coward, J.I.G., Puglisi, M., Trani, L., Wotherspoon, A., Sharma, B., Cook, G., Ashley, S., Gunapala, R., Chua, S., Popat, S. |
| المصدر: | In European Journal of Cancer 2012 48(1):68-74 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2011.10.033 |